UCB's Global Corporate Website
Welcome to UCB in the United States


Find U.S. news and updates from UCB, a global biopharmaceutical company focused on creating value for people living with severe diseases, such as epilepsy, Parkinson’s disease, psoriasis, osteoporosis, myasthenia gravis,  rheumatoid arthritis, psoriatic arthritis, non-radiographic axial spondyloarthritis, and more. 

Spotlight Story

No results



UCB U.S. News

UCB presents new data highlighting developments across expansive neurology portfolio at 76th…

Read More

Our Leadership and Legacy in Epilepsy and Rare Syndromes

Read More

Striving to Make HStory: UCB’s Mission to Raise Awareness for Hidradenitis Suppurativa

Read More

Twitter Feed

For More Information